Progressive Supranuclear Palsy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy
Condition:   Progressive Supranuclear Palsy Intervention:   Diagnostic Test: 18F-PMPBB3 Sponsor:   Chang Gung Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2020 Category: Research Source Type: clinical trials

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
Condition:   Progressive Supranuclear Palsy (PSP) Interventions:   Drug: antisense oligonucleotide;   Drug: placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2020 Category: Research Source Type: clinical trials